Marshall Wace, LLP Covetrus, Inc. Transaction History

Marshall Wace, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.69 - $20.91 $569,864 - $575,924	27,543 Added 60.36%	73,175 $1.53 Million
Q2 2022 Aug 15, 2022	SELL	$13.8 - $20.82 $2.92 Million - $4.4 Million	-211,333 Reduced 82.24%	45,632 $946,000
Q1 2022 May 16, 2022	BUY	$15.96 - $18.87 $2.2 Million - $2.6 Million	137,607 Added 115.29%	256,965 $4.31 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $20.37 $3.54 Million - $4.3 Million	-211,119 Reduced 63.88%	119,358 $2.38 Million
Q3 2021 Nov 15, 2021	BUY	$18.14 - $27.03 $5.99 Million - $8.93 Million	330,477 New	330,477 $5.99 Million
Q2 2021 Aug 13, 2021	SELL	$25.24 - $30.86 $199,698 - $244,164	-7,912 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.29 - $39.89 $223,830 - $315,609	7,912 New	7,912 $237,000
Q2 2020 Aug 13, 2020	SELL	$6.46 - $19.27 $114,923 - $342,813	-17,790 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.64 - $15.23 $100,335 - $270,941	17,790 New	17,790 $145,000
Q4 2019 Feb 14, 2020	SELL	$8.8 - $14.93 $24,613 - $41,759	-2,797 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$11.76 - $25.57 $32,892 - $71,519	2,797 New	2,797 $33,000

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.